ArticleHeliyon2024
Optogenetic stimulation of the "Zusanli" acupoint alleviates inflammatory pain through active Wnt/β-Catenin and MAPK signaling pathway in rats.
Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Stage-Specific Mechanisms of Manual Acupuncture and Electroacupuncture in Inflammatory Pain: A Time-Dependent Review.Journal of pain research · 2026Review
- Electroacupuncture Ameliorates Neuroinflammatory Injury in CPSP Rats by Inhibiting the LncRNA MEG3-Mediated Wnt/β-Catenin Signaling Pathway.Neurochemical research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Inflammatory pain, an important form of common pain, negatively influences the quality of life. Pathway-selective optogenetic control is a popular tool in neuronal function research; however, attempts to modulate rodent behavior using pathway-selective optogenetics remain unverified. We developed a methodology for pathway-selective optogenetics in rats, focusing on the delivery of recombinant adeno-associated virus (rAAV) containing channelrhodopsin-2 (ChR2) injected at the "Zusanli" acupoints to the dorsal root ganglia (DRG) and toes, which is a part of the complex neuron network. Optogenetic stimulation of gamma-aminobutyric acid (GABA) projections to the "Zusanli" acupoints delivered several rAAV9-GAD1-ChR2-mcherry particles to the spinal cord horn (SCDH) and DRG and few rAAV9-GAD1-ChR2-mcherry particles to toes, thereby evoking an analgesic effect in complete Freund's adjuvant (CFA) rats similar to those of acupuncture. Furthermore, blue light stimulation (LED) and electroacupuncture (EA) reduced inflammatory pain in CFA rats, as evidenced by the changes in the paw edema, paw withdrawal latency (PWL), and paw withdrawal threshold (PWT) values. Further exploration of the mechanisms underlying this phenomenon revealed that optogenetic stimulation upregulates the decarboxylase-65 (GAD65) and decarboxylase-67 (GAD67) protein levels and downregulates the levels of GABA transporter-1 (GAT1) and GABA transporter-3 (GAT3) to alleviate inflammatory pain. The activation of the p38 mitogen-activated protein kinases (MAPK) and Wnt signal transduction pathways decreased the release of interleukin 6 (IL-6), interleukin 10 (IL-10), and tumor necrosis factor-α (TNFα). These findings indicate that optogenetic stimulation of the "Zusanli" acupoint alleviated inflammatory pain.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.